[Prospects for treating intraocular traumatic hemorrhage using a new fibrinolytic hemase].
Therapy of intraocular traumatic hemorrhage with the new drug hemaz is an important problem of ophthalmic traumatology. Seventy patients (76 eyes) with intraocular hemorrhages of traumatic origin were treated. Forty four patients (44 eyes) presented with hyphemas and 32 (32 eyes) with hemophthalmia. The results of hemaz therapy were compared with those of traditional treatment. The results confirm the high efficacy of hemaz which was well tolerated with sub-conjunctival and parabulbar injection. Indications for the use of this drug in clinical practice were formulated: it is recommended for the treatment of posttraumatic and postoperative hyphemas of any volume, including pupil hyphema, and for partial posttraumatic hemophthalmia.
Stepanov
A V
AV
Bolkvadze
E R
ER
Belogurov
A A
AA
Tovarova
I I
II
D005130:Eye Hemorrhage / Q000188:drug therapy* / Q000209:etiology / Q000503:physiopathology; D005131:Eye Injuries / Q000150:complications* / Q000503:physiopathology; D005343:Fibrinolytic Agents / Q000627:therapeutic use*; D006801:Humans; D014792:Visual Acuity
D005343:Fibrinolytic Agents